Related Experiment Video
Updated: Feb 2, 2026

Optimization of Renal Organoid and Organotypic Culture for Vascularization, Extended Development, and Improved Microscopy Imaging
Published on: March 28, 2020
Improving survival in end-stage renal disease: A case study
M H Elsensohn1,2,3, E Dantony1,2,3, J Iwaz1,2,3
1Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique-Bioinformatique, Lyon, France.
This study shows that multi-state models and crude probability of death can assess end-stage renal disease (ESRD) treatment benefits. This helps in managing patient survival and understanding ESRD-related versus unrelated deaths.
Area of Science:
- Nephrology
- Biostatistics
- Public Health
Background:
- Increasing life expectancy leads to more end-stage renal disease (ESRD) patients.
- Renal replacement therapies (RRTs) have improved survival rates for ESRD patients.
- Current RRT practices' impact on patient survival requires investigation.
Purpose of the Study:
- To investigate how current RRT practices affect patient survival.
- To estimate ESRD-related and ESRD-unrelated death proportions.
- To quantify the impact of RRT on patient survival using restricted mean survival time (RMST).
Main Methods:
- Utilized a multi-state model for RRT transitions and death.
- Employed the "crude probability of death" concept to differentiate death causes.
- Solved Kolmogorov differential equations to predict patient trajectories.
- Quantified survival benefit using RMST compared to healthy individuals.
Main Results:
- ESRD-unrelated deaths were minimal in young patients but significant in older adults (≥70 years).
- Older patients without diabetes had a higher proportion of expected death due to longer lifespans.
- For 75-year-old men starting RRT, RMST was 61% (with diabetes) and 69% (without diabetes) of healthy men's RMST.
Conclusions:
- Multi-state models combined with "crude probability of death" are effective for ESRD research.
- This approach aids in evaluating RRT benefits and optimizing long-term patient management.
- Understanding death causes is crucial for personalized ESRD care and survival prediction.
Related Concept Videos
Serum Studies: Renal Function Tests
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Comparing the Survival Analysis of Two or More Groups

